FdaApplication

ANDA 065419

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2008-06-24

Products (2)

ProductActive ingredientStrengthDosage form
AZITHROMYCINAZITHROMYCINEQ 200MG BASE/5MLFOR SUSPENSION;ORAL
AZITHROMYCINAZITHROMYCINEQ 100MG BASE/5MLFOR SUSPENSION;ORAL

2 products